Real-world treatment pattern and clinical outcomes among patients with metastatic renal cell (mRCC) carcinoma post PD-1/PD-L1 immuno-oncology (IO) therapies. This is an ASCO Meeting Abstract from the ...

The following is a summary of “Risk factors for renal insufficiency and survival implications after radical nephrectomy and ...

Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma: An updated report. Updated outcomes of patients with metastatic non-clear cell renal cell carcinoma ...

Background: A standard of care for the treatment of small renal masses is partial nephrectomy. The open and laparoscopic approaches have been well described in the literature. Robotic assistance ...

Background Laparoscopic radical nephrectomy (LRN) is the actual gold-standard for the treatment of clinically localized renal cell carcinoma (RCC) (cT1–2 with no indications for nephron-sparing ...

Deferred cytoreductive nephrectomy is associated with better survival compared with upfront surgery, including among fit patients receiving immunotherapy. Deferred cytoreductive nephrectomy (CN ...

Avelumab plus axitinib was effective and safe in real-world advanced kidney cancer, with outcomes matching clinical trials, according to AVION study findings.

A highly vascularized cancer that is especially reliant on tumor endothelial cells is clear cell renal cell ... 3D model of renal carcinoma. They used similar techniques to successfully culture both ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Annual Symposium held in San ...

There are currently 82,000 incident cases of RCC annually in the United States (account for 3–5% of cancers), with 15,000 deaths annually in the United States. The overall 5-year mortality risk is ~30 ...

Patients with metastatic renal cell carcinoma staged pT1-4 Nx M1 were ... All patients had tumor nephrectomy or metastatic surgery at the University of Göttingen, Urology Department or at an ...